Press Release: Humacyte Announces Pricing of $30.0 Million Registered Direct Offering

Dow JonesOct 4 20:00

Humacyte Is Maintained at Buy by EF Hutton

Dow JonesOct 2 03:59 · Ratings

Humacyte Price Target Maintained With a $25.00/Share by EF Hutton

Dow JonesOct 2 03:59 · Ratings

TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 1 03:31 · Ratings

Analysts Conflicted on These Healthcare Names: Humacyte (HUMA) and Baxter International (BAX)

TipRanksOct 1 03:10 · Ratings

Humacyte, Inc. (HUMA) Increases Yet Falls Behind Market: What Investors Need to Know

Yahoo FinanceSep 27 06:15